Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 160,348 Less Arrow 38,502 Less Arrow 0
Financial expenses 12,468 Less Arrow 1,534 More Arrow 1,922
Earnings before taxes -216,298 More Arrow -112,606 Less Arrow -133,229
EBITDA -202,011 More Arrow -106,099 Less Arrow -122,424
Total assets 438,945 More Arrow 461,425 More Arrow 500,577
Current assets 310,107 More Arrow 343,154 More Arrow 407,927
Current liabilities 219,340 Less Arrow 158,083 More Arrow 159,727
Equity capital 115,081 More Arrow 283,924 More Arrow 313,932
- share capital 4,489 Less Arrow 4,120 Less Arrow 4,082
Employees (average) 89 Less Arrow 68 Less Arrow 50

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 26.2% More Arrow 61.5% More Arrow 62.7%
Turnover per employee 1,802 Less Arrow 566 Less Arrow 0
Profit as a percentage of turnover -134.9% Less Arrow -292.5%
Return on assets (ROA) -46.4% More Arrow -24.1% Less Arrow -26.2%
Current ratio 141.4% More Arrow 217.1% More Arrow 255.4%
Return on equity (ROE) -188.0% More Arrow -39.7% Less Arrow -42.4%
Change turnover 121,648 Less Arrow 38,502 Less Arrow 0
Change turnover % 314%
Chg. No. of employees 21 Less Arrow 18 Less Arrow 11
Chg. No. of employees % 31% More Arrow 36% Less Arrow 28%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.